Total Payments
$324,893
2024 Payments
$36,217
Companies
82
Transactions
1,623
Medicare Patients
107
Medicare Billing
$12,855
Payment Breakdown by Category
Other$240,015 (73.9%)
Food & Beverage$30,898 (9.5%)
Consulting$28,453 (8.8%)
Travel$24,471 (7.5%)
Education$1,057 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $135,308 | 56 | 41.6% |
| Honoraria | $104,707 | 23 | 32.2% |
| Food and Beverage | $30,898 | 1,428 | 9.5% |
| Consulting Fee | $28,453 | 10 | 8.8% |
| Travel and Lodging | $24,471 | 70 | 7.5% |
| Education | $1,057 | 36 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Karyopharm Therapeutics Inc. | $125,316 | 85 | $0 (2024) |
| Incyte Corporation | $94,352 | 129 | $0 (2024) |
| Celgene Corporation | $34,117 | 68 | $0 (2024) |
| PFIZER INC. | $30,129 | 216 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $6,131 | 52 | $0 (2024) |
| Astellas Pharma US Inc | $5,228 | 38 | $0 (2024) |
| Eisai Inc. | $3,949 | 52 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $3,164 | 176 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $3,069 | 74 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $2,924 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $36,217 | 186 | Karyopharm Therapeutics Inc. ($32,150) |
| 2023 | $61,168 | 190 | Karyopharm Therapeutics Inc. ($41,226) |
| 2022 | $71,521 | 204 | Karyopharm Therapeutics Inc. ($51,777) |
| 2021 | $21,394 | 185 | Incyte Corporation ($9,048) |
| 2020 | $29,336 | 129 | Celgene Corporation ($14,219) |
| 2019 | $31,650 | 219 | PFIZER INC. ($11,895) |
| 2018 | $43,315 | 253 | Incyte Corporation ($20,577) |
| 2017 | $30,292 | 257 | Incyte Corporation ($18,530) |
All Payment Transactions
1,623 individual payment records from CMS Open Payments — Page 1 of 65
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | SOBI, INC | DOPTELET (Drug) | Education | In-kind items and services | $93.95 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/19/2024 | PFIZER INC. | TALZENNA (Drug), XTANDI | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/17/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $3.08 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/16/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Honoraria | Cash or cash equivalent | $8,150.00 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Travel and Lodging | In-kind items and services | $449.97 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Travel and Lodging | In-kind items and services | $339.01 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Travel and Lodging | Cash or cash equivalent | $89.62 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Travel and Lodging | Cash or cash equivalent | $42.00 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | Cash or cash equivalent | $13.19 | General |
| Category: Oncology | ||||||
| 12/12/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: Immunology | ||||||
| 12/09/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $28.42 | General |
| 12/05/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: Oncology | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $16.63 | General |
| Category: Oncology | ||||||
| 11/26/2024 | Astellas Pharma US Inc | Vyloy (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Oncology | ||||||
| 11/25/2024 | ARRAY BIOPHARMA INC | XALKORI (Drug), LORBRENA, BRAFTOVI | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Novocure Inc. | Optune Lua (NovoTTF-200T) (Device) | Food and Beverage | Cash or cash equivalent | $28.71 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $1.78 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 21 | 53 | $10,335 | $3,539 |
| 2022 | 2 | 32 | 59 | $13,961 | $4,599 |
| 2021 | 1 | 12 | 27 | $7,776 | $2,656 |
| 2020 | 2 | 42 | 59 | $7,572 | $2,061 |
Total Patients
107
Total Services
198
Medicare Billing
$12,855
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 21 | 53 | $10,335 | $3,539 | 34.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 18 | 34 | $6,836 | $2,499 | 36.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 14 | 25 | $7,125 | $2,101 | 29.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 12 | 27 | $7,776 | $2,656 | 34.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 26 | 35 | $5,844 | $1,455 | 24.9% |
| G2063 | Qualified nonphysician healthcare professional online assessment and management service, for an established patient, for up to seven days, cumulative time during the 7 days; 21 or more minutes | Office | 2020 | 16 | 24 | $1,728 | $605.64 | 35.0% |
About Dr. Rahul Naik, M.D
Dr. Rahul Naik, M.D is a Internal Medicine healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2007. The National Provider Identifier (NPI) number assigned to this provider is 1992999031.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rahul Naik, M.D has received a total of $324,893 in payments from pharmaceutical and medical device companies, with $36,217 received in 2024. These payments were reported across 1,623 transactions from 82 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($135,308).
As a Medicare-enrolled provider, Naik has provided services to 107 Medicare beneficiaries, totaling 198 services with total Medicare billing of $12,855. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Los Angeles, CA
- Active Since 08/31/2007
- Last Updated 08/24/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1992999031
Products in Payments
- XPOVIO (Drug) $125,316
- JAKAFI (Drug) $94,068
- XTANDI (Drug) $26,825
- Revlimid (Drug) $15,085
- INREBIC (Drug) $14,173
- Nubeqa (Drug) $5,489
- ORGOVYX (Drug) $3,965
- Lenvima (Drug) $3,949
- NINLARO (Drug) $2,815
- LYNPARZA (Drug) $2,154
- BOSULIF (Drug) $1,420
- ZEJULA (Drug) $971.87
- IBRANCE (Drug) $959.38
- OPDIVO (Biological) $951.42
- Xtandi (Drug) $835.61
- GILOTRIF (Drug) $820.62
- TECENTRIQ (Biological) $700.80
- KEYTRUDA (Biological) $552.40
- Stivarga (Drug) $533.30
- KISQALI (Drug) $531.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Los Angeles
Dr. Thomas Magee, Md, MD
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Dr. Julio Gutierrez, Md, MD
Internal Medicine — Payments: $920,439
Internal Medicine $920,439
Dr. Mohammad Kamgar, M.d, M.D
Internal Medicine — Payments: $471,176
Internal Medicine $471,176
Dr. Caroline Piatek, M.d,, M.D,
Internal Medicine — Payments: $468,526
Internal Medicine $468,526
Gottfried Konecny, Md, MD
Internal Medicine — Payments: $399,651
Internal Medicine $399,651
Dr. Elizabeth Volkmann, Md, MD
Internal Medicine — Payments: $397,666
Internal Medicine $397,666